Venaseal
Payments companies reported to CMS as associated with Venaseal. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Venaseal, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Venaseal
These are the largest totals companies reported as associated with Venaseal. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kathleen Gibson | Bellevue, WA | Vascular Surgery | $105,418.80 |
| Misaki Kiguchi | Washington, DC | Vascular Surgery | $62,101.60 |
| Jon George | Philadelphia, PA | Interventional Cardiology | $52,960.86 |
| Kathleen Ozsvath | Albany, NY | Vascular Surgery | $42,257.70 |
| Ramona Gupta | Chicago, IL | Vascular & Interventional Radiology | $38,435.03 |
| Tamam Mohamad | Detroit, MI | Interventional Cardiology | $28,828.02 |
| Peter Schneider | Honolulu, HI | Vascular Surgery | $28,824.78 |
| Dania Daye | Framingham, MA | Vascular & Interventional Radiology | $28,439.71 |
| Michael Vasquez | Amherst, NY | Vascular Surgery | $27,660.28 |
| Dvora Nelson | North Olmsted, OH | Surgery | $25,744.39 |
Prescribed Venaseal?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.